Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic

Purpose Cancer patients have many medical and psychosocial needs, which may increase during the COVID-19 pandemic. We sought to (1) risk-stratify hematology/oncology patients using general medicine and cancer-specific methods to identify those at high risk for acute care utilization, (2) measure the correlation between two risk stratification methods, and (3) perform a telephone-based needs assessment with intervention for high-risk patients. Methods Patients were risk-stratified using a general medical health composite score (HCS) and a cancer-specific risk (CSR) stratification based on disease and treatment characteristics. The correlation between HCS and CSR was measured using Spearman’s correlation. A multi-disciplinary team developed a focused needs assessment script with recommended interventions for patients categorized as high-risk by either method. The number of patient needs identified and referrals for services made in the first month of outreach are reported. Results A total of 1697 patients were risk-stratified, with 17% high-risk using HCS and 22% high-risk using CSR. Correlation between HCS and CSR was modest (ρ = 0.41). During the first month of the pilot, 286 patients were called for outreach with 245 contacted (86%). Commonly identified needs were financial difficulties (17%), uncontrolled symptoms (15%), and interest in advance care planning (13%), resulting in referral for supportive services for 33% of patients. Conclusion There is a high burden of unmet medical and psychosocial needs in hematology/oncology patients during the COVID-19 pandemic. A telephone-based outreach program results in the identification of and intervention for these needs; however, additional cancer-specific risk models are needed to improve targeting to high-risk patients..

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:29

Enthalten in:

Supportive care in cancer - 29(2020), 3 vom: 12. Okt., Seite 1161-1164

Sprache:

Englisch

Beteiligte Personen:

Osterman, Chelsea K. [VerfasserIn]
Triglianos, Tammy [VerfasserIn]
Winzelberg, Gary S. [VerfasserIn]
Nichols, Angela D. [VerfasserIn]
Rodriguez-O’Donnell, Julia [VerfasserIn]
Bigelow, Sharon M. [VerfasserIn]
van Deventer, Hendrik [VerfasserIn]
Sanoff, Hanna K. [VerfasserIn]
Ray, Emily M. [VerfasserIn]

Links:

Volltext [lizenzpflichtig]

Themen:

COVID-19
Coronavirus
Malignancy
Quality improvement
Risk assessment

RVK:

RVK Klassifikation

Anmerkungen:

© Springer-Verlag GmbH Germany, part of Springer Nature 2020

doi:

10.1007/s00520-020-05744-y

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2123081191

Zugang & Verfügbarkeit




Zugehörige Publikationen/Bände

    Haven't found what you're looking for?